scholarly journals Spread of ductal carcinoma in situ into a phyllodes breast tumour: a case report

2021 ◽  
Vol 7 (3) ◽  
Author(s):  
Fabio Mauri ◽  
Ilaria Follesa Vitillo ◽  
Emanuela Stochino Loi ◽  
Maurizio Nicola D’Alterio ◽  
Stefano Angioni ◽  
...  
Keyword(s):  
Case Report ◽  
Ductal Carcinoma In Situ ◽  
Carcinoma In Situ ◽  
Ductal Carcinoma ◽  
Breast Tumour

Development of quality indicators for treatment of ductal carcinoma in situ (DCIS) of the breast using a multidisciplinary Delphi process.

2012 ◽  
Vol 30 (34_suppl) ◽  
pp. 248-248
Author(s):  
May Lynn Quan ◽  
William Ghali ◽  
Peter S. Craighead ◽  
Heather E. Bryant
Keyword(s):  
Clinical Practice ◽  
Quality Indicators ◽  
Clinical Practice Guidelines ◽  
Ductal Carcinoma In Situ ◽  
Practice Guidelines ◽  
Carcinoma In Situ ◽  
Ductal Carcinoma ◽  
Breast Tumour ◽  
Delphi Consensus

248 Background: Ductal carcinoma in situ (DCIS) of the breast accounts for ~30% of new breast cancer diagnoses. Measuring quality of DCIS treatment is problematic due to its distinctively different clinical behaviour from invasive breast carcinoma, where standard outcomes such as mortality are not relevant. Therefore, we sought to develop clinically relevant quality indicators to evaluate treatment of DCIS. Methods: A Delphi consensus process was undertaken using a multidisciplinary panel of nine clinical and methodologic experts from Ontario, Alberta, and British Columbia. Panel members were nominated based on membership in provincial breast tumour site groups. Four criteria for a good quality indicator were used; the indicator measures a treatment that benefits the patient, there is support from scientific literature or professional consensus for benefit; the indicator is under control of the health care provider, the indicator is extractable from the medical record. Candidate indicators were identified from published clinical practice guidelines in North America. Three iterations of ratings using Likert scale rankings were utilized to identify final quality indicators, which were then prioritized. Results: A total of 10 candidate indicators were identified from four clinical practice guidelines encompassing the diagnosis, surgery and adjuvant treatment components of DCIS. A total of eight indicators were identified and prioritized (Table). Conclusions: We successfully developed practical quality indicators for evaluating the treatment of DCIS, which can be used in any jurisdiction to measure key performance benchmarks and identify variations in care warranting intervention or improvement. [Table: see text]

scholarly journals Adenomyoepithelioma with Ductal Carcinoma In Situ: A Case Report and Review of the Literature

2013 ◽  
Vol 2013 ◽  
pp. 1-3 ◽  
Author(s):  
Sanjay Warrier ◽  
Sang Hwang ◽  
Martha Ghaly ◽  
Alex Matthews
Keyword(s):  
Case Report ◽  
Literature Review ◽  
Ductal Carcinoma In Situ ◽  
Growth Pattern ◽  
Carcinoma In Situ ◽  
Breast Screening ◽  
Ductal Carcinoma ◽  
Review Of The Literature ◽  
Microglandular Adenosis

Adenomyoepithelioma (AME) with microglandular adenosis-like growth pattern and superimposed ductal carcinoma in situ (DCIS) was identified in a 55-year-old female after biopsy of an atypical lesion identified through routine breast screening. A literature review reveals that this association has rarely been described.

Sign in / Sign up

Export Citation Format

Share Document